Published in Obesity and Diabetes Week, July 10th, 2006
This is the largest and longest study to examine the effects of Actos on measures of the atherosclerotic disease process in patients with type 2 diabetes, most of whom had no clinical evidence of heart disease.
"While earlier and smaller studies found that Actos reduced carotid intima-media thickness, given the size and duration of the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.